Product Name | MF | CAS | Details |
---|
Ethyl 3-Aminocrotonate (2 x 200 mg) (Ethyl (Z)-3-aminobut-2-enoate) | C6H11NO2 | 626-34-6 | Details |
Ethyl Laurate (500 mg) | C14H28O2 | 106-33-2 | Details |
Ethionamide (200 mg) | C8H10N2S | 536-33-4 | Details |
Ethisterone (50 mg) | C21H28O2 | 434-03-7 | Details |
Ethopabate (125 mg) | C12H15NO4 | 59-06-3 | Details |
Ethosuximide (500 mg) | C7H11NO2 | 77-67-8 | Details |
Ethotoin (500 mg) | C11H12N2O2 | 86-35-1 | Details |
Ethyl Lauroyl Arginate (200 mg) | C20H41ClN4O3 | 60372-77-2 | Details |
Ethyl Palmitate (500 mg) | C18H36O2 | 628-97-7 | Details |
Epoprostenol Related Compound A (15 mg) (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid) (COLD SHIPMENT REQUIRED) | C20H34O6 | 58962-34-8 | Details |
Epoprostenol Sodium (100 mg) (COLD SHIPMENT REQUIRED) | C20H33NaO5 | 61849-14-7 | Details |
Eprosartan Mesylate (50 mg) ((E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate) | C24H28N2O7S2 | 144143-96-4 | Details |
Eprosartan Related Compound D (15 mg) (4-(bromomethyl)benzoic acid) | C8H7BrO2 | 6232-88-8 | Details |
Eptifibatide Dimer (10 mg) | C70H98N22O18S4 | 1505451-00-2 | Details |
Equilin (25 mg) | C18H20O2 | 474-86-2 | Details |
Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) | C28H44O | 50-14-6 | Details |
Ergonovine Maleate (150 mg) (List Chemical) | C23H27N3O6 | 129-51-1 | Details |
Ergotaminine (100 mg) | C33H35N5O5 | 639-81-6 | Details |
Erlotinib Related Compound A (25 mg) (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride) | C25H30ClN3O5 | 299912-59-7 | Details |
Erythromycin Ethylsuccinate (200 mg) | C43H75NO16 | 1264-62-6 | Details |
Erythromycin Gluceptate (200 mg) (DISCONTINUED) | C37H67NO13.C7H14O8 | 23067-13-2 | Details |
Erythromycin Stearate (200 mg) | C55H103NO15 | 643-22-1 | Details |
Erythropoietin for Bioassays | C42H73NO16 | 113427-24-0 | Details |
Escin (350 mg) | C55H86O24 | 11072-93-8 | Details |
Escitalopram Open Ring (25 mg) (4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile) | C20H23FN2O2 | 103146-25-4 | Details |
Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate) | 2C20H23FN2O2.C20H18O8 | 128173-53-5 | Details |
Esomeprazole Strontium (20 mg) | C17H23N3O4SSr | 934714-36-0 | Details |
Estradiol (500 mg) | C18H24O2.H2O | 35380-71-3 | Details |
Estradiol Benzoate (250 mg) | C25H28O3 | 50-50-0 | Details |
Estradiol Cypionate (200 mg) | C26H36O3 | 313-06-4 | Details |
Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol) | C18H22O2 | 7291-41-0 | Details |
Estriol (100 mg) | C18H24O3 | 50-27-1 | Details |
Estrone (200 mg) | C18H22O2 | 53-16-7 | Details |
Estropipate (500 mg) | C22H32N2O5S | 7280-37-7 | Details |
Ethambutol Hydrochloride (200 mg) | C10H24N2O2.2ClH | 1070-11-7 | Details |
Ethambutol Related Compound A (15 mg) ((2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride) | C10H25ClN2O2 | 32454-69-6 | Details |
Eleutheroside E (15 mg) (Beta-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-4,1-phenylene)bis-) | C34H46O18 | 39432-56-9 | Details |
Ellagic Acid (25 mg) | C14H6O8 | 476-66-4 | Details |
Emedastine Difumarate (100 mg) | C25H34N4O9 | 87233-62-3 | Details |
Emetine Hydrochloride (300 mg) | C29H44Cl2N2O5 | 7083-71-8 | Details |
Enalaprilat (300 mg) | C18H26N2O6 | 84680-54-6 | Details |
Enflurane (1 mL) (DISCONTINUED) | C3H2ClF5O | 13838-16-9 | Details |
Enoxaparin Sodium (300 mg) | C57H82N4Na4O53S3 | 679809-58-6 | Details |
Epilactose (200 mg) | C12H22O11 | 50468-56-9 | Details |
Epinine Hydroiodide | C9H13NO2 | 501-15-5 | Details |
Epirubicin Hydrochloride (200 mg) | C27H30ClNO11 | 56390-09-1 | Details |
Epitetracycline Hydrochloride (250 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | C22H25ClN2O8 | 23313-80-6 | Details |
Eletriptan Hydrobromide (200 mg) (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate) | C22H29BrN2O3S | 273211-28-2 | Details |
Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole) | C14H17BrN2 | 143322-57-0 | Details |
Eleutheroside B (15 mg) (Syringin) | C17H24O9 | 118-34-3 | Details |
Dissolution Performance Verification Standard - Prednisone (30 tablets) | Details |
Disulfiram (200 mg) | C10H20N2S4 | 97-77-8 | Details |
Dithienyl ketone (25 mg) (Di-2-thienylmethanone) | C9H6OS2 | 704-38-1 | Details |
Divalproex Sodium (200 mg) | C8H17NaO2 | 76584-70-8 | Details |
Docosahexaenoic Acid (250 mg) ((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid) | C22H32O2 | 6217-54-5 | Details |
Dobutamine Hydrochloride (400 mg) | C18H24ClNO3 | 49745-95-1 | Details |
Dobutamine Related Compound C (50 mg) (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride) | C21H30ClNO3 | 51062-14-7 | Details |
Docosyl Ferulate (50 mg) | C32H54O4 | 101927-24-6 | Details |
Docusate Calcium (500 mg) | C20H40CaO7S | 128-49-4 | Details |
Dofetilide (200 mg) | C19H27N3O5S2 | 115256-11-6 | Details |
Dofetilide Related Compound A (25 mg) (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide) | C18H25N3O5S2 | 176447-94-2 | Details |
Dofetilide Related Compound B (25 mg) (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide) | C19H27N3O6S2 | 144449-71-8 | Details |
Dolasetron Mesylate (125 mg) | C20H24N2O6S | 878143-33-0 | Details |
Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride) | C10H16ClNO2 | 148091-18-3 | Details |
Dorzolamide Related Compound B (15 mg) ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | C10H17ClN2O4S3 | 120279-37-0 | Details |
Doxapram Hydrochloride (200 mg) | C24H30N2O2.ClH.H2O | 7081-53-0 | Details |
Doxazosin Mesylate (200 mg) | C24H29N5O8S | 77883-43-3 | Details |
Doxepin Hydrochloride (500 mg) | C19H22ClNO | 1229-29-4 | Details |
Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one) | C14H10O2 | 4504-87-4 | Details |
Doxorubicin Hydrochloride (50 mg) | C27H29NO11.ClH | 25316-40-9 | Details |
Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) | C17H17N3O | 2170-37-8 | Details |
Drometrizole Trisiloxane (200 mg) | C24H39N3O3Si3 | 155633-54-8 | Details |
Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol) | C13H11N3O | 2440-22-4 | Details |
Dried Aluminum Hydroxide Gel (200 mg) | AlH3O3 | 21645-51-2 | Details |
Doxylamine Succinate (300 mg) | C21H28N2O5 | 562-10-7 | Details |
Doxycycline Monohydrate (100 mg) | C22H26N2O9 | 17086-28-1 | Details |
Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) | C17H17N3O | 98809-58-6 | Details |
Dyphylline (200 mg) | C10H14N4O4 | 479-18-5 | Details |
Echinacoside (15 mg) | C35H46O20 | 82854-37-3 | Details |
Econazole Nitrate (250 mg) | C18H16Cl3N3O4 | 24169-02-6 | Details |
Dyclonine Hydrochloride (200 mg) | C18H28ClNO2 | 536-43-6 | Details |
Duloxetine Regioisomer (25 mg) (2-(2-(3-(methylamino)propyl)thiophen-3-yl)naphthalen-1-ol) | C18H19NOS | 940291-11-2 | Details |
Duloxetine Phthalamide (25 mg) ((S)-2-(methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamoyl)benzoic acid) | C26H23NO4S | 199191-67-8 | Details |
Duloxetine Phenylcarbamate (50 mg) (phenyl (S)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate) | C25H23NO3S | 947686-09-1 | Details |
Duloxetine Alcohol (25 mg) ((R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol) | C8H13NOS | 116539-57-2 | Details |
Duloxetine 4-Naphthyl Isomer Hydrobromide (25 mg) (4-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol, hydrobromide) | C18H20BrNOS | 949096-01-9 | Details |
Eflornithine Hydrochloride (150 mg) | C6H15ClF2N2O3 | 96020-91-6 | Details |
Egeline (10 mg) | C18H19NO3 | 456-12-2 | Details |
Droxidopa (100 mg) | C9H11NO5 | 23651-95-8 | Details |
Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone) | C24H30O3 | 90457-65-1 | Details |
Droperidol (250 mg) | C22H22FN3O2 | 548-73-2 | Details |
Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) | C30H43ClN2O3 | 1309476-91-2 | Details |
Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) | 57265-33-5 | Details |
Edetate Calcium Disodium (200 mg) | C10H16CaN2Na2O10 | 6766-87-6 | Details |
Edetic Acid (200 mg) | C10H16N2O8 | 60-00-4 | Details |
Efavirenz (200 mg) | C14H9ClF3NO2 | 154598-52-4 | Details |
Efavirenz Racemic (20 mg) ((+/-)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | C14H9ClF3NO2 | 177530-93-7 | Details |
Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) | C13H11ClF3NO | 209414-27-7 | Details |
Product Total: Product Page: | ||||
60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 |